APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cancer Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cancer Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025185 pages

Choose your research edition.

Industry ResearchCancer Vaccines Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Vaccines Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Cancer Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Vaccines Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cancer Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cancer Vaccines include Merck, Pfizer, Glaxosmithkline, Serum Institute of India, Sanpower Group, Sanofi Pasteur, CSL Limited and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cancer Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cancer Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cancer Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cancer Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Cancer Vaccines Segment by Company

Merck

Pfizer

Glaxosmithkline

Serum Institute of India

Sanpower Group

Sanofi Pasteur

CSL Limited

Astellas Pharma

Cancer Vaccines Segment by Type

Preventive Cancer Vaccines

Therapeutic Cancer Vaccines

Cancer Vaccines Segment by Application

Cervical Cancer

Prostate Cancer

Others

Cancer Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cancer Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cancer Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cancer Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cancer Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cancer Vaccines Industry Trends Table 2. Cancer Vaccines Industry Drivers Table 3. Cancer Vaccines Industry Opportunities and Challenges Table 4. Cancer Vaccines Industry Restraints Table 5. Global Cancer Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cancer Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cancer Vaccines Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Cancer Vaccines Sales Market Share by Manufacturers Table 9. Global Cancer Vaccines Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Cancer Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cancer Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cancer Vaccines Manufacturers, Product Type & Application Table 13. Global Cancer Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cancer Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Preventive Cancer Vaccines Table 17. Major Manufacturers of Therapeutic Cancer Vaccines Table 18. Global Cancer Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 20. Global Cancer Vaccines Sales by Type (2027-2032) & (k units) Table 21. Global Cancer Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Cancer Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Cancer Vaccines Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Cancer Vaccines Revenue by Type (2021-2026) & (k units) Table 25. Global Cancer Vaccines Revenue by Type (2027-2032) & (k units) Table 26. Global Cancer Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Cancer Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cervical Cancer Table 29. Major Manufacturers of Prostate Cancer Table 30. Major Manufacturers of Others Table 31. Global Cancer Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 33. Global Cancer Vaccines Sales by Application (2027-2032) & (k units) Table 34. Global Cancer Vaccines Sales Market Share by Application (2021-2026) Table 35. Global Cancer Vaccines Sales Market Share by Application (2027-2032) Table 36. Global Cancer Vaccines Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Cancer Vaccines Revenue by Application (2021-2026) & (k units) Table 38. Global Cancer Vaccines Revenue by Application (2027-2032) & (k units) Table 39. Global Cancer Vaccines Revenue Market Share by Application (2021-2026) Table 40. Global Cancer Vaccines Revenue Market Share by Application (2027-2032) Table 41. Global Cancer Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Cancer Vaccines Sales by Region (2021-2026) & (k units) Table 43. Global Cancer Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Cancer Vaccines Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Cancer Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Cancer Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 48. North America Cancer Vaccines Sales by Country (2027-2032) & (k units) Table 49. Europe Cancer Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 51. Europe Cancer Vaccines Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Cancer Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Cancer Vaccines Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Cancer Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Cancer Vaccines Sales by Country (2027-2032) & (k units) Table 58. Global Cancer Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Cancer Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Cancer Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Cancer Vaccines Revenue Market Share by Region (2021-2026) Table 62. Global Cancer Vaccines Revenue Market Share by Region (2027-2032) Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Cancer Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merck Cancer Vaccines Product Portfolio Table 67. Merck Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Cancer Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Pfizer Cancer Vaccines Product Portfolio Table 72. Pfizer Recent Development Table 73. Glaxosmithkline Company Information Table 74. Glaxosmithkline Business Overview Table 75. Glaxosmithkline Cancer Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Glaxosmithkline Cancer Vaccines Product Portfolio Table 77. Glaxosmithkline Recent Development Table 78. Serum Institute of India Company Information Table 79. Serum Institute of India Business Overview Table 80. Serum Institute of India Cancer Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Serum Institute of India Cancer Vaccines Product Portfolio Table 82. Serum Institute of India Recent Development Table 83. Sanpower Group Company Information Table 84. Sanpower Group Business Overview Table 85. Sanpower Group Cancer Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sanpower Group Cancer Vaccines Product Portfolio Table 87. Sanpower Group Recent Development Table 88. Sanofi Pasteur Company Information Table 89. Sanofi Pasteur Business Overview Table 90. Sanofi Pasteur Cancer Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sanofi Pasteur Cancer Vaccines Product Portfolio Table 92. Sanofi Pasteur Recent Development Table 93. CSL Limited Company Information Table 94. CSL Limited Business Overview Table 95. CSL Limited Cancer Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. CSL Limited Cancer Vaccines Product Portfolio Table 97. CSL Limited Recent Development Table 98. Astellas Pharma Company Information Table 99. Astellas Pharma Business Overview Table 100. Astellas Pharma Cancer Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Astellas Pharma Cancer Vaccines Product Portfolio Table 102. Astellas Pharma Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Cancer Vaccines Distributors List Table 106. Cancer Vaccines Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Cancer Vaccines Product Image Figure 2. Global Cancer Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Cancer Vaccines Sales (2021-2032) & (k units) Figure 5. Global Cancer Vaccines Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cancer Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Preventive Cancer Vaccines Image Figure 9. Therapeutic Cancer Vaccines Image Figure 10. Global Cancer Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Cancer Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Cancer Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Cancer Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Cancer Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cancer Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Cervical Cancer Image Figure 17. Prostate Cancer Image Figure 18. Others Image Figure 19. Global Cancer Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Cancer Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cancer Vaccines Sales Market Share by Application (2021-2032) Figure 22. Global Cancer Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Cancer Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cancer Vaccines Revenue Market Share by Application (2021-2032) Figure 25. North America Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Cancer Vaccines Sales Market Share by Country (2021-2032) Figure 27. U.S. Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Cancer Vaccines Sales Market Share by Country (2021-2032) Figure 32. Germany Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Cancer Vaccines Sales Market Share by Country (2021-2032) Figure 39. China Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Cancer Vaccines Sales Market Share by Country (2021-2032) Figure 47. Brazil Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Cancer Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Cancer Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Cancer Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Cancer Vaccines Revenue (2021-2032) & (US$ Million) Figure 58. North America Cancer Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Cancer Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. Europe Cancer Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Cancer Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Cancer Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Cancer Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Cancer Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cancer Vaccines Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Cancer Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccines
Applications
  • Cervical Cancer
  • Prostate Cancer
  • Others
Companies covered
  • Merck
  • Pfizer
  • Glaxosmithkline
  • Serum Institute of India
  • Sanpower Group
  • Sanofi Pasteur
  • CSL Limited
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cancer Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cancer Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cancer Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cancer Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cancer Vaccines Market Dynamics
  1. 2.1 Cancer Vaccines Industry Trends
  2. 2.2 Cancer Vaccines Industry Drivers
  3. 2.3 Cancer Vaccines Industry Opportunities and Challenges
  4. 2.4 Cancer Vaccines Industry Restraints
3 Cancer Vaccines Market by Manufacturers
  1. 3.1 Global Cancer Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cancer Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cancer Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cancer Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cancer Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cancer Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Cancer Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cancer Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cancer Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cancer Vaccines Tier 1, Tier 2, and Tier 3
4 Cancer Vaccines Market by Type
  1. 4.1 Cancer Vaccines Type Introduction
  2. 4.1.1 Preventive Cancer Vaccines
  3. 4.1.2 Therapeutic Cancer Vaccines
  4. 4.2 Global Cancer Vaccines Sales by Type
  5. 4.2.1 Global Cancer Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cancer Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Cancer Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cancer Vaccines Revenue by Type
  9. 4.3.1 Global Cancer Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cancer Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Cancer Vaccines Revenue Market Share by Type (2021-2032)
5 Cancer Vaccines Market by Application
  1. 5.1 Cancer Vaccines Application Introduction
  2. 5.1.1 Cervical Cancer
  3. 5.1.2 Prostate Cancer
  4. 5.1.3 Others
  5. 5.2 Global Cancer Vaccines Sales by Application
  6. 5.2.1 Global Cancer Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cancer Vaccines Sales by Application (2021-2032)
  8. 5.2.3 Global Cancer Vaccines Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cancer Vaccines Revenue by Application
  10. 5.3.1 Global Cancer Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cancer Vaccines Revenue by Application (2021-2032)
  12. 5.3.3 Global Cancer Vaccines Revenue Market Share by Application (2021-2032)
6 Global Cancer Vaccines Sales by Region
  1. 6.1 Global Cancer Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cancer Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Cancer Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Cancer Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cancer Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cancer Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cancer Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cancer Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cancer Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cancer Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cancer Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cancer Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cancer Vaccines Revenue by Region
  1. 7.1 Global Cancer Vaccines Revenue by Region
  2. 7.1.1 Global Cancer Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cancer Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Cancer Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Cancer Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cancer Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Cancer Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cancer Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Cancer Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cancer Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cancer Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cancer Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cancer Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Cancer Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Cancer Vaccines Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Cancer Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Cancer Vaccines Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Glaxosmithkline
  14. 8.3.1 Glaxosmithkline Company Information
  15. 8.3.2 Glaxosmithkline Business Overview
  16. 8.3.3 Glaxosmithkline Cancer Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Glaxosmithkline Cancer Vaccines Product Portfolio
  18. 8.3.5 Glaxosmithkline Recent Developments
  19. 8.4 Serum Institute of India
  20. 8.4.1 Serum Institute of India Company Information
  21. 8.4.2 Serum Institute of India Business Overview
  22. 8.4.3 Serum Institute of India Cancer Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Serum Institute of India Cancer Vaccines Product Portfolio
  24. 8.4.5 Serum Institute of India Recent Developments
  25. 8.5 Sanpower Group
  26. 8.5.1 Sanpower Group Company Information
  27. 8.5.2 Sanpower Group Business Overview
  28. 8.5.3 Sanpower Group Cancer Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanpower Group Cancer Vaccines Product Portfolio
  30. 8.5.5 Sanpower Group Recent Developments
  31. 8.6 Sanofi Pasteur
  32. 8.6.1 Sanofi Pasteur Company Information
  33. 8.6.2 Sanofi Pasteur Business Overview
  34. 8.6.3 Sanofi Pasteur Cancer Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Pasteur Cancer Vaccines Product Portfolio
  36. 8.6.5 Sanofi Pasteur Recent Developments
  37. 8.7 CSL Limited
  38. 8.7.1 CSL Limited Company Information
  39. 8.7.2 CSL Limited Business Overview
  40. 8.7.3 CSL Limited Cancer Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CSL Limited Cancer Vaccines Product Portfolio
  42. 8.7.5 CSL Limited Recent Developments
  43. 8.8 Astellas Pharma
  44. 8.8.1 Astellas Pharma Company Information
  45. 8.8.2 Astellas Pharma Business Overview
  46. 8.8.3 Astellas Pharma Cancer Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Astellas Pharma Cancer Vaccines Product Portfolio
  48. 8.8.5 Astellas Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cancer Vaccines Value Chain Analysis
  2. 9.1.1 Cancer Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cancer Vaccines Production Mode & Process
  6. 9.2 Cancer Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cancer Vaccines Distributors
  9. 9.2.3 Cancer Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst